Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma
TORONTO, ON / ACCESSWIRE / September 17, 2024 / Ripple Therapeutics today announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a next generation, fully biodegradable, sustained release drug delivery intracameral implant with repeat dosing capabilities to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). This collaboration leverages AbbVie's expertise in eye care and Ripple's innovative drug delivery platform.
Ripple's patented technology platform is based on a discovery that drugs can be engineered into controlled release pharmaceuticals without the use of polymers or excipients. These proprietary prodrugs undergo surface erosion to give zero order release kinetics and are highly customizable to tailor both drug dose and duration. Because there are no polymers or excipients, once the drug is gone, the implant is gone with no pro-inflammatory degradation products, which supports repeat dosing.
"We're pleased to partner with AbbVie, a worldwide leader in ophthalmic therapeutics," said Tom Reeves, President and Chief Executive Officer, Ripple Therapeutics. "By combining our drug delivery platform with AbbVie's research, clinical, regulatory and commercial capabilities, we hope to deliver a meaningful impact on the lives of people living with glaucoma."
Millions of people are living with glaucoma, one of the leading causes of vision loss. New treatment options are needed to help patients challenged with topical drops or who are at risk for vision loss and looking for alternative treatment options.
"At AbbVie, we strive to find innovative solutions to build our portfolio of vision-preserving therapies," said Michael Robinson, M.D., Vice President and Therapeutic Area Head, Ophthalmology, AbbVie. "We are excited to partner with Ripple to further advance the development of RTC-620."
Under terms of the agreement, Ripple will lead preclinical development of RTC-620. Upon exercise of the option, AbbVie will lead the clinical and commercialization activities. Ripple will receive an upfront payment of $21.8 million from AbbVie and is eligible to receive up to $290 million in aggregate option fees and milestones, as well as tiered royalties on net sales.
About Ripple Therapeutics
Ripple Therapeutics Corporation is a privately held clinical stage company focused on improving ophthalmic therapeutics with controllable sustained delivery implants without the use of polymers or excipients. Our novel therapeutics provide better outcomes for patients, easier management of care for physicians and lower cost for payors. www.rippletherapeutics.com
Piper Sandler acted as the exclusive financial advisor to Ripple.
For further information:
Media: Julie Fotheringham, jfotheringham@rippletherapeutics.com, 416-951-7988
SOURCE: Ripple Therapeutics
View the original press release on accesswire.com
Ripple Therapeutics
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Addressing Climate Change by Changing Our Food Systems14.1.2025 14:00:00 CET | Press release
WASHINGTON, D.C. / ACCESSWIRE / January 14, 2025 / The year 2024 was the hottest year on record. For the first time the average global temperature rose to 1.6C above preindustrial levels, exceeding the 1.5C vital to preventing accelerating climate change. The effects of climate change are now visible on every continent.Image: www.freepik.com Up to a third of global greenhouse gas production to date can be attributed to animal agriculture and food systems. Yet, most climate change solutions neglect the importance of food systems in climate change mitigation. In the article, ‘Solving Climate Change Requires Changing Our Food Systems,' published in leading scientific journal Oxford Open Climate Change, prominent scientists from around the world propose that the pressing nature of irreversible climate change requires rethinking our food systems. Lead researcher Dr Feigin and her co-authors assert that "we must undertake a global shift to a fundamentally plant-based diet and a gradual globa
The AI Gap: New Survey Reveals Enterprises Are Lagging in the High-Stakes AI Adoption Race14.1.2025 09:00:00 CET | Press release
Nearly 40% of Employees Say Their Organization Is Falling Behind Competitors Due to Slow Adoption NEW YORK, NY / ACCESSWIRE / January 14, 2025 / A striking new survey from Unily uncovers an alarming truth: despite the excitement around AI as a transformative force, many enterprises struggle to adopt the technology in meaningful ways. The result is a growing gap between AI "haves" and "have nots," where enterprises adopting AI tools for their people are making quicker gains than those without. Additionally, employees who are open to using AI tools increasingly want more exposure to them and may even choose employers who are early AI adopters over those who are slower to adapt. The differences between companies and employees that embrace AI and those that don't include a downstream impact on Organizational Velocity. Organizational Velocity is defined as the ability to make sharp pivots, accelerate decision-making, and eliminate operational friction necessary to harness AI's full potentia
Walkbase Launches Game-Changing Millimeter Wave Sensor Solution at NRF's Big Show 202513.1.2025 08:00:00 CET | Press release
New analytics technology set to provide crucial in-store metrics for retail media attribution. NEW YORK CITY, NEW YORK / ACCESSWIRE / January 13, 2025 / STRATACACHE company Walkbase, the leading in-store analytics solutions provider for retailers, today unveils its new millimeter wave sensor technology. The Walkbase Millimeter Wave Sensor Solution provides retailers and premises owners a powerful way to accurately measure in-store customer behavior without collecting or divulging the personally identifying information (PII) of customers.Walkbase Millimeter Wave Sensor Solution NRF attendees learning about Walkbase's Millimeter Wave Sensor Solution The Walkbase Millimeter Wave Sensor Solution will be on display, along with retail solutions from other members of the STRATACACHE family of technology companies including PRN and Scala, at NRF at booth 5213 (level 3). "For retailers looking to track shopper activity in their store, without the risk of collecting unauthorized data, the millim
AML Incubator Launches Compliance Solution for European MSBs and VASPs Facing MiCA Regulatory Challenges10.1.2025 10:45:00 CET | Press release
AML Incubator (AMLI), a leading compliance consultancy, has introduced a new service package to assist European Money Service Businesses (MSBs) and Virtual Asset Service Providers (VASPs) in establishing operations in Canada. The service is designed to help businesses manage complex regulatory challenges arising from the European Union's Markets in Crypto-Assets (MiCA) regulation. VANCOUVER, BC / ACCESSWIRE / January 10, 2025 / The MiCA regulations, part of the EU's digital finance package, imposes strict compliance rules for crypto-asset issuers and service providers. These include licensing, registration, and transparency requirements aimed at improving market stability and investor protection. While MiCA brings greater oversight to the industry, many small and mid-sized MSBs and VASPs are struggling to meet these new demands within the required timelines. As deadlines approach, businesses are exploring alternative jurisdictions that provide clearer regulatory pathways without sacrif
IXOPAY & Riskified Announce Partnership to Boost Fraud Prevention and Enhance Enterprise Payment Orchestration9.1.2025 00:00:00 CET | Press release
The partnership will help ecommerce customers securely expand their businesses by leveraging omnichannel payment orchestration with AI fraud detection LEHI, UT and NEW YORK, NY / ACCESSWIRE / January 9, 2025 / IXOPAY, a leading enterprise payment orchestration platform, and Riskified (NYSE:RSKD), a leader in ecommerce fraud and risk intelligence, today announced a strategic partnership to enhance payment security, reduce fraud challenges and increase payment operation resilience. As global payment ecosystems become more complex, so do the associated risks. IXOPAY and Riskified are teaming up to provide businesses with a seamless, secure and efficient way to enhance their payments orchestration and effectively repel fraud threats. IXOPAY + Riskified IXOPAY and Riskified partnership This partnership combines IXOPAY's payment orchestration, tokenization, and flexible payment optimization capabilities with Riskified's AI-powered fraud and risk intelligence platform. Businesses using this c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom